Minor water retention or numbness in extremities at higher doses
(PubMed) Xue YZ, Wang LX, Liu HZ, Qi XW, Wang XH, Ren HZ
Hybrid Meeting w/ Virtual Lecture
Most GLP-1 agents require gradual dose escalation to minimize gastrointestinal side effects, meaning patients start at lower-than-maintenance titration doses and increase incrementally over 820 weeks depending on the specific medication
When less melanin pigment is made your skin becomes lighter
During 1,036,587 person-years of follow-up, cholangiocarcinoma occurred among 92 patients with use of GLP-1-receptor agonists (incidence rate, 26 per 100,000 patient-years) and among 157 patients with use of sulfonylureas (incidence rate, 23 per 100,000 patient-years)